Capella Intelligent Subsystems Inc. (f.k.a. Capella Photonics), a San Jose, Calif.
Expresso Fitness, a Sunnyvale, Calif.-based provider of interactive cardio fitness systems, has raised $9.3 million in Series C funding. Sierra Ventures led the deal, and was joined by return backer Enterprise Partners Venture Capital. www.expressofitness.com
Smurfit Kappa Group, a cardboard packaging company formed via the 2005 merger of Ireland-based Jefferson Smurfit and The Netherlands-based Kappa, raised Euro 1.3 billion via an IPO on the Irish Stock Exchange and a secondary listing on the London Stock Exchange. Shareholders include Cinven, CVC Capital and Madison Dearborn Partners. The Euro 16.5 per share […]
Perseus-Soros Management has sold its remaining 1.7 million share stake in drug company Adams Respiratory Therapeutics (Nasdaq: ARXT) for around $44 million, according to The New York Post. www.adamslaboratories.com
Sun Capital Partners has raised the ceiling of its fifth buyout fund to $6 billion, after originally targeting $4 billion, according to Buyouts Magazine. Its prior fund closed on $1.5 billion in 2005. www.suncappart.com
Jeffrey McDermott has resigned as one of three co-heads of global I-banking at UBS, effective June 30.
Michael Ellwein and Roderick Young have joined Three Arch Partners as venture partners. Ellwein has spent the past 17 years with Medtronic, most recently as vice president and chief development officer. Young previously served as CEO of former Three Arch portfolio company Vivant Medical (sold to Tyco). www.threearchpartners.com
Tragara Pharmaceuticals Inc., a San Diego-based drug company focused on cancer and inflammatory diseases, has raised $40 million in Series A funding. Backers include Domain Associates, ProQuest Investments, Morgenthaler Ventures, Oxford Biosceince Partners and Mitsubishi International Corp. www.tragarapharma.com
HaloSource Inc., a Bothell, Wash.-based antimicrobial technology company focusing on safe water and infection control, has raised $6 million in VC funding. Unilver Ventures led the deal, and was joined by return backers like Alexander Hutton Venture Partners, and Britannia Holdings and WRF Capital. www.halosource.com
Proteogenix Inc., a Portland, Ore.-based developer of proteomic and genomic tests to detect and monitor fetal disorders, confirmed that it has raised $20 million in Series B funding. PE Week Wire first reported the news last week. New Leaf Ventures and TPG Ventures co-led the deal, and were joined by return backer Burrill & Co. […]